A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
Clinical trial NCT06139055 · UNKNOWN
Trial details
- NCT number
- NCT06139055
- Sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2024-03-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.